Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Recruiting now · Not applicable

Conditions studied: Ovarian Neoplasm, Depressive Symptoms, Quality of Life

In brief

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

Key facts

Study ID

NCT05752448

Run by

Baylor College of Medicine

People needed

120

Starts

2023-10-01

Expected to finish

2027-04-15

Last updated by the study team

2026-04-03

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Stage 2-4 ovarian cancer
• Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy
• Within 6 months of completion of initial treatment (continued maintenance therapy okay)
• Able to provide consent in English or Spanish

You may not qualify if…

• Admission to hospice at the completion of treatment for ovary cancer

Where it is running

• Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center — Houston, Texas, United States (enrolling)
• Harris Health Smith Clinic — Houston, Texas, United States (enrolling)
• UT Southwestern Parkland Health and Hospital System — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.